Urinary Incontinence Therapeutics Market Set To Explode Opportunities, Future Scope 2025-2032 | Astellas Pharma, Pfizer
The Global Urinary Incontinence Therapeutics Market is estimated to be valued at USD 4.68 Bn in 2025 and is expected to reach USD 6.37 Bn by 2032. BURLINGAME, CA, UNITED STATES, December 3, 2025 /EINPresswire.com/ -- The Global Urinary …